The bcl-2 Gene Product Prevents Programmed Cell Death of Ventricular Myocytes
- 2 September 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (5) , 1580-1585
- https://doi.org/10.1161/01.cir.96.5.1580
Abstract
Background To formally test whether the antiapoptotic protein bcl-2 would prevent programmed cell death in cardiac muscle cells provoked by p53, a known trigger of apoptosis in a variety of differe...Keywords
This publication has 28 references indexed in Scilit:
- Bcl-XL and Bcl-2 repress a common pathway of cell death.The Journal of Experimental Medicine, 1995
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell deathCell, 1995
- Reperfusion injury induces apoptosis in rabbit cardiomyocytes.Journal of Clinical Investigation, 1994
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric MiceScience, 1993
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus.Journal of Clinical Investigation, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992